Tirzepatide 20mg

Tirzepatide at a glance

Tirzepatide, developed under the code LY3298176, is a synthetic 39-residue peptide whose backbone is modeled on glucose-dependent insulinotropic polypeptide, with substitutions that also give it activity at the GLP-1 receptor. A fatty diacid side chain attached through a linker lets the molecule bind serum albumin, which slows its clearance. Its molecular formula is C225H348N48O68, with a molecular weight of roughly 4813.5 g/mol, and listings here supply it as a freeze-dried powder for laboratory work.

Price and availability

This is Cyprus Peptides‘s single 20mg vial, dispatched from Cyprus. At $363.00 for the kit, that works out to $18.15 per mg. Across 22 brands listing Tirzepatide here, the middle half of prices falls between $0.475 and $1.00 per mg; this kit is above the typical range. Your payment waits in escrow until you confirm the parcel arrived, and only then is it released to the brand.

What it is studied for

Researchers describe tirzepatide as an imbalanced dual agonist: in published receptor assays it shows comparatively strong GIP-receptor activity alongside more modest GLP-1-receptor engagement. Both targets are class B G protein-coupled receptors that signal largely through cAMP. In metabolic models, this combined input is studied for glucose-dependent insulin release from pancreatic beta cells, reduced glucagon output, delayed stomach emptying and central effects on appetite circuits. Whether GIP-receptor activity contributes something distinct, for example in fat tissue, or partly acts through receptor desensitization remains an open and actively debated question in the literature.

Research and regulatory status

Few compounds sold as research peptides have a clinical record this extensive. A large late-stage trial program supported regulatory approvals for type 2 diabetes and, later, for chronic weight management, and further studies have examined obstructive sleep apnea, fatty liver disease, heart failure and cardiovascular outcomes. That record belongs to the pharmaceutical product, however. Vials listed on GLP1 Forum Escrow are research-grade material for laboratory study, and their quality depends on the individual brand, which is why third-party test reports matter.

Checking the lab data

A credible report should show a mass-spectrometry result consistent with the expected mass of about 4813.5 Da; the lipidated side chain makes truncated or incompletely modified material comparatively easy to spot. HPLC purity should be stated as a percentage with the chromatogram attached, not just a pass mark. Look for measured peptide content per vial compared with the label claim, plus a uniform white lyophilized cake and a batch number and test date that match the vial.

No independent report is attached to this listing yet. You can compare brands that publish one on the Tirzepatide page or browse the lab reports directory.

Listing details

Compound

Tirzepatide

Synonyms

LY3298176

Class

Dual GIP / GLP-1 receptor agonist

Format

Lyophilized (freeze-dried) powder

Molecular formula

C225H348N48O68

Molecular weight

~4813.5 g/mol

Vial strength

20mg

Total content

20 mg

Price per mg

$18.15

Sold by

Cyprus Peptides

Ships from

Cyprus

Lab report

Not yet published

Storage and preparation

Keep unopened freeze-dried vials cold, sealed and out of the light; moisture is what degrades a lyophilized cake fastest. After reconstitution, refrigerate the solution and work within the stability window your protocol sets.

Concentration arithmetic: one 20 mg vial dissolved in 2 mL gives 10 mg/mL, or 20 mg/mL in 1 mL. The Research Lab calculator in your dashboard handles any other volume.

Buyer questions

Supplied for laboratory research only. Not for human or veterinary use, and not a substitute for any prescription medicine. Nothing on this page is medical advice.